Zealand Pharma A/S (CPH: ZEAL)

Zealand Pharma Balance Sheet

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	TTM	2023	2022	2021	2020	2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7,155	449.31	1,069	1,129	960.22	1,081
Short-Term Investments	-	-	-	-	-	299.45
Trading Asset Securities	1,777	1,184	108.61	299.04	297.35	-
Cash & Short-Term Investments	8,933	1,633	1,178	1,428	1,258	1,381
Cash Growth	427.82%	38.65%	-17.53%	13.56%	-8.91%	19.09%
Accounts Receivable	67.87	122.36	115.62	153.45	46.48	0.75
Other Receivables	50.33	16.44	21.6	21.56	15.44	15.04
Receivables	118.2	138.8	137.22	175.02	61.93	15.79
Inventory	0.8	7.94	1.29	118.44	65.04	-
Prepaid Expenses	60.34	-	-	-	35.16	30.76
Total Current Assets	9,148	1,780	1,316	1,722	1,420	1,427
Property, Plant & Equipment	146.34	149.85	165.49	221.45	213.04	125.34
Long-Term Investments	837	21.38	37.84	26.91	32.33	35.63
Other Intangible Assets	11.98	12.26	-	53.79	57.49	2.48
Long-Term Accounts Receivable	-	15.79	18.11	29.09	-	-
Long-Term Deferred Tax Assets	0.96	0.93	2.02	13.53	8.37	-
Other Long-Term Assets	11.65	-	-	1.27	31.04	9.01
Total Assets	10,156	1,980	1,540	2,068	1,762	1,600
Accounts Payable	227.3	91.61	180.76	266.39	70.38	57.53
Accrued Expenses	-	85.2	-	-	36.67	42.93
Current Portion of Leases	29.85	16.66	14.73	14.9	14.07	7.69
Current Income Taxes Payable	-	-	-	-	30.39	0.61
Current Unearned Revenue	-	-	-	53.03	53.18	56.25
Other Current Liabilities	-	91.12	-	-	150.56	30.12
Total Current Liabilities	257.15	284.58	195.49	334.32	355.26	195.13
Long-Term Debt	276.79	-	401.35	647.91	-	-
Long-Term Leases	83.35	102.58	108	124.63	116.05	78.07
Long-Term Unearned Revenue	-	-	-	14.55	44.59	83.64
Other Long-Term Liabilities	142.22	-	19.06	18.43	16.74	-
Total Liabilities	759.51	387.15	723.9	1,140	532.64	356.84
Common Stock	71	58.75	51.7	43.63	39.8	36.06
Additional Paid-In Capital	14,678	6,406	4,921	-	3,472	2,650
Retained Earnings	-5,376	-4,895	-4,172	-	-2,290	-1,444
Treasury Stock	-	-	-	-	-1.7	-
Comprensive Income & Other	22.66	22.7	14.62	884.17	8.98	-
Shareholders' Equity	9,396	1,593	815.91	927.8	1,229	1,243
Total Liabilities & Equity	10,156	1,980	1,540	2,068	1,762	1,600
Total Debt	389.99	119.23	524.08	787.43	130.12	85.76
Net Cash (Debt)	9,358	1,514	653.77	640.72	1,127	1,295
Net Cash Growth	493.95%	131.55%	2.04%	-43.17%	-12.92%	11.69%
Net Cash Per Share	155.31	26.75	14.15	14.95	29.38	38.30
Filing Date Shares Outstanding	70.92	58.38	51.47	43.22	39.55	35.99
Total Common Shares Outstanding	70.92	58.38	51.47	43.22	39.74	35.99
Working Capital	8,891	1,495	1,121	1,387	1,064	1,232
Book Value Per Share	132.48	27.28	15.85	21.47	30.94	34.53
Tangible Book Value	9,384	1,581	815.91	874.01	1,172	1,240
Tangible Book Value Per Share	132.32	27.07	15.85	20.22	29.49	34.46
Buildings	-	-	-	-	34.1	13.77
Machinery	-	78.57	82.83	106.63	101.18	69.65
Construction In Progress	-	-	0.87	12.11	3.02	14
Leasehold Improvements	-	38.91	38.19	36.6	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.